Selective Serotonin Reuptake Inhibitors
Reference110 articles.
1. Marks DM, Park MH, Ham BJ, Han C, Patkar AA, Masand PS, Pae CU, Paroxetine: safety and tolerability issues, Expert Opin Drug Saf. 2008 Nov;7(6):783–94.
2. Leonard B and Tollfeson, G. Focus on SSRIs: broadening the spectrum of clinical use. J. Clin. Psychiatry. 55: 459–466 (1994).
3. Menting JE, Honig A, Verhey FR, Hartmans M, Rozendaal N, de Vet HC, van Praag HM. Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side effects. Int Clin Psychopharmacol. 11 (3): 165–75 (Sep 1996).
4. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord. 58(1): 19–36 (Apr 2000).
5. Otto MW, Tuby KS, Gould RA, McLean RY, Pollack MH. An effect-size analysis of the relative efficacy and tolerability of serotonin reuptake inhibitors for panic disorder. Am J Psychiatry 158(12): 1989–92 (Dec 2001).